Cagrilintide
Amylin Analog
CAS: 1415456-99-3
Formula: C194H312N54O59S2
M.W.: 4425.1146 g/mol
Purity: 99%+ HPLC Verified
Ref No.: CAG-0005VI
Ref No.: CAG-0010VI
For Research Use Only (RUO)
Not for human or veterinary use.
Cagrilintide
Category
GLP / Metabolic Research
CAS Number
1415456-99-3
Form Factor
Lyophilized Powder
In stock, ready to ship
Ships same day before 12pm PST
Products are shipped in lyophilized powder form.
Cagrilintide is a long-acting acylated amylin analog that mimics the satiety-signaling effects of amylin, co-secreted with insulin from pancreatic beta cells. It reduces food intake, slows gastric emptying, and modulates satiety receptor pathways, with additive effects observed when combined with GLP-1 receptor agonists in preclinical models.
Description
Cagrilintide is a long-acting acylated amylin analog that mimics the satiety-signaling effects of amylin, co-secreted with insulin from pancreatic beta cells. It reduces food intake, slows gastric emptying, and modulates satiety receptor pathways, with additive effects observed when combined with GLP-1 receptor agonists in preclinical models.Chemical Information
CAS Number
1415456-99-3
Purity
99%+
Molecular Formula
C194H312N54O59S2
Molar Mass
4425.0 g/mol
Form Factor
Lyophilized Powder
Research Applications
- Metabolic Research: Cagrilintide is studied as a long-acting acylated amylin analog that mimics the satiety signaling of endogenous amylin. Research examines its mechanism of food intake reduction through area postrema activation, gastric emptying delay, and glucagon suppression.
- Combination Metabolic Research: Cagrilintide is studied in combination with GLP-1 receptor agonists for additive adipose tissue endpoint changes. Research demonstrates that targeting both amylin and GLP-1 pathways simultaneously produces greater fat mass reduction than either mechanism alone.
- Endocrinology Research: Cagrilintide is studied for insights into pancreatic beta-cell co-secretion signaling. Research examines how amylin analog administration affects insulin secretion dynamics, glucagon counter-regulation, and postprandial glucose excursions.
- Gastroenterology Research: Cagrilintide is studied for gastric emptying modulation and postprandial physiology. Research examines the mechanisms and magnitude of gastric emptying delay and its contribution to satiety signaling.
Storage Conditions
Unreconstituted
Store at -20°C to 4°C (freezer or refrigerator). Stable for 24+ months.
Reconstituted
Refrigerate at 2–8°C. Use within 30 days for optimal stability.
Avoid
Repeated freeze-thaw cycles, direct sunlight, and temperatures above 25°C.
Safety & Compliance
- Wear nitrile gloves and safety goggles when handling research compounds.
- Work in a clean, controlled environment (laminar flow hood recommended).
- Dispose of sharps and used materials in approved biohazard containers.
- This product is for laboratory research use only (RUO) — not for human or veterinary use.
Quality Assurance Standards
Each production lot is subjected to rigorous analytical evaluation to meet pharmaceutical-grade specifications. Full testing results and procedural documentation are furnished through the accompanying Certificate of Analysis (COA) with every shipment.
Certificate of Analysis
Latest COA for Cagrilintide — independently tested via HPLC and Mass Spectrometry.
Testing Methodology
Every batch undergoes a multi-stage analytical pipeline before release. Results are compiled into the Certificate of Analysis (COA) included with each order.
- • HPLC — High-Performance Liquid Chromatography confirms peptide purity ≥98%.
- • Mass Spectrometry — Validates molecular identity and correct sequence.
- • Endotoxin (LAL) — Limulus Amebocyte Lysate assay ensures endotoxin levels are within safe limits.
- • Sterility — Microbial contamination testing per USP standards.
Learn More About Peptides
Explore our research library covering purity, synthesis, storage, solubility, and more.
Research Database
Browse peer-reviewed studies, clinical trials, and scientific sources behind our peptide resources.
You May Also Like
-
$85 – $139.99
Tesamorelin
GH / Neuro / Misc ResearchThis product has multiple variants. The options may be chosen on the product page View Details -
$79.99
MOTS-c
GLP / Metabolic ResearchThis product has multiple variants. The options may be chosen on the product page View Details -
$124.99
Semax (Spray)
GH / Neuro / Misc ResearchThis product has multiple variants. The options may be chosen on the product page View Details -
$99.99
NAD+ (Spray)
GH / Neuro / Misc ResearchThis product has multiple variants. The options may be chosen on the product page View Details
For GH-mediated body composition Research
For Mitochondrial metabolic support Research
Popular Product
Popular Product
Description
Cagrilintide is a long-acting acylated amylin analog that mimics the satiety-signaling effects of amylin, co-secreted with insulin from pancreatic beta cells. It reduces food intake, slows gastric emptying, and modulates satiety receptor pathways, with additive effects observed when combined with GLP-1 receptor agonists in preclinical models.Chemical Information
CAS Number
1415456-99-3
Purity
99%+
Molecular Formula
C194H312N54O59S2
Molar Mass
4425.0 g/mol
Form Factor
Lyophilized Powder
Research Applications
- Metabolic Research: Cagrilintide is studied as a long-acting acylated amylin analog that mimics the satiety signaling of endogenous amylin. Research examines its mechanism of food intake reduction through area postrema activation, gastric emptying delay, and glucagon suppression.
- Combination Metabolic Research: Cagrilintide is studied in combination with GLP-1 receptor agonists for additive adipose tissue endpoint changes. Research demonstrates that targeting both amylin and GLP-1 pathways simultaneously produces greater fat mass reduction than either mechanism alone.
- Endocrinology Research: Cagrilintide is studied for insights into pancreatic beta-cell co-secretion signaling. Research examines how amylin analog administration affects insulin secretion dynamics, glucagon counter-regulation, and postprandial glucose excursions.
- Gastroenterology Research: Cagrilintide is studied for gastric emptying modulation and postprandial physiology. Research examines the mechanisms and magnitude of gastric emptying delay and its contribution to satiety signaling.
Storage Conditions
Unreconstituted
Store at -20°C to 4°C (freezer or refrigerator). Stable for 24+ months.
Reconstituted
Refrigerate at 2–8°C. Use within 30 days for optimal stability.
Avoid
Repeated freeze-thaw cycles, direct sunlight, and temperatures above 25°C.
Safety & Compliance
- Wear nitrile gloves and safety goggles when handling research compounds.
- Work in a clean, controlled environment (laminar flow hood recommended).
- Dispose of sharps and used materials in approved biohazard containers.
- This product is for laboratory research use only (RUO) — not for human or veterinary use.
Quality Assurance Standards
Each production lot is subjected to rigorous analytical evaluation to meet pharmaceutical-grade specifications. Full testing results and procedural documentation are furnished through the accompanying Certificate of Analysis (COA) with every shipment.
Certificate of Analysis
Latest COA for Cagrilintide — independently tested via HPLC and Mass Spectrometry.
Testing Methodology
Every batch undergoes a multi-stage analytical pipeline before release. Results are compiled into the Certificate of Analysis (COA) included with each order.
- • HPLC — High-Performance Liquid Chromatography confirms peptide purity ≥98%.
- • Mass Spectrometry — Validates molecular identity and correct sequence.
- • Endotoxin (LAL) — Limulus Amebocyte Lysate assay ensures endotoxin levels are within safe limits.
- • Sterility — Microbial contamination testing per USP standards.
Learn More About Peptides
Explore our research library covering purity, synthesis, storage, solubility, and more.
Research Database
Browse peer-reviewed studies, clinical trials, and scientific sources behind our peptide resources.
